Cargando…

Metformin and cancer: An existing drug for cancer prevention and therapy

Metformin is a standard clinical drug used to treat type 2 diabetes mellitus (T2DM) and polycystic ovary syndrome. Recently, epidemiological studies and meta-analyses have revealed that patients with T2DM have a lower incidence of tumor development than healthy controls and that patients diagnosed w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zi, Fuming, Zi, Huapu, Li, Yi, He, Jingsong, Shi, Qingzhi, Cai, Zhen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772929/ https://www.ncbi.nlm.nih.gov/pubmed/29422962 http://dx.doi.org/10.3892/ol.2017.7412

Ejemplares similares

Fibroblast activation protein α in tumor microenvironment: Recent progression and implications (Review)
por: ZI, FUMING, et al.
Publicado: (2015)

Metformin for aging and cancer prevention
por: Anisimov, Vladimir N.
Publicado: (2010)

Metformin: On Ongoing Journey across Diabetes, Cancer Therapy and Prevention
por: Pulito, Claudio, et al.
Publicado: (2013)

Metformin: A promising drug for human cancers
por: Wu, Hongnian, et al.
Publicado: (2022)

Quercetin induces cell apoptosis of myeloma and displays a synergistic effect with dexamethasone in vitro and in vivo xenograft models
por: He, Donghua, et al.
Publicado: (2016)

Metformin and Fibrosis: A Review of Existing Evidence and Mechanisms
por: Wu, Maoyan, et al.
Publicado: (2021)

The beneficial effects of metformin on cancer prevention and therapy: a comprehensive review of recent advances
por: Saraei, Pouya, et al.
Publicado: (2019)

Advances in metformin-based metabolic therapy for non-small cell lung cancer
por: Chen, Na, et al.
Publicado: (2022)

Preventative and Therapeutic Effects of Metformin in Gastric Cancer: A New Contribution of an Old Friend
por: Zhang, Jing, et al.
Publicado: (2020)

Comparative review of drug–drug interactions with epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer
por: Xu, Zi-Yi, et al.
Publicado: (2019)

How are MCPIP1 and cytokines mutually regulated in cancer-related immunity?
por: Xu, Ruyi, et al.
Publicado: (2020)

Frontiers in Anti-Cancer Drug Discovery: Challenges and Perspectives of Metformin as Anti-Angiogenic Add-On Therapy in Glioblastoma
por: Guarnaccia, Laura, et al.
Publicado: (2021)

Metformin as a potential combination therapy with existing front-line antibiotics for Tuberculosis
por: Vashisht, Rohit, et al.
Publicado: (2015)

Existing Drugs Considered as Promising in COVID-19 Therapy
por: Janik, Edyta, et al.
Publicado: (2021)

Metformin: current clinical applications in nondiabetic patients with cancer
por: Chen, Kailin, et al.
Publicado: (2020)

Recycling existing drugs for cancer therapy: delivering low cost cancer care
por: Pantziarka, Pan, et al.
Publicado: (2014)

Interleukin-32α promotes the proliferation of multiple myeloma cells by inducing production of IL-6 in bone marrow stromal cells
por: Lin, Xuanru, et al.
Publicado: (2017)

Preventive and Therapeutic Effect of Metformin in Head and Neck Cancer: A Concise Review
por: Bouland, Cyril, et al.
Publicado: (2023)

A pan-cancer analysis of the role of argininosuccinate synthase 1 in human tumors
por: Ding, Qiang, et al.
Publicado: (2023)

Metformin targets multiple signaling pathways in cancer
por: Lei, Yong, et al.
Publicado: (2017)

Metformin for the Prevention of Bladder Cancer Recurrence: Is it Effective?
por: Heidari, Fatemeh, et al.
Publicado: (2016)

Metformin and blood cancers
por: Cunha Júnior, Ademar Dantas, et al.
Publicado: (2018)

Metformin: An Old Drug with New Applications
por: Zhou, Joseph, et al.
Publicado: (2018)

Pleiotropic Effects of Metformin on Cancer
por: Schulten, Hans-Juergen
Publicado: (2018)

Metformin and Cancer, an Ambiguanidous Relationship
por: Skuli, Sarah J., et al.
Publicado: (2022)

Immunotherapy: Review of the Existing Evidence and Challenges in Breast Cancer
por: Hu, Yun, et al.
Publicado: (2023)

HSP90 inhibitors and cancer: Prospects for use in targeted therapies (Review)
por: Li, Zi-Nan, et al.
Publicado: (2022)

Molecular and Cellular Mechanisms of Metformin in Cervical Cancer
por: Chen, Ya-Hui, et al.
Publicado: (2021)

Diabetes, pancreatic cancer, and metformin therapy
por: Gong, Jun, et al.
Publicado: (2014)

Ataxia telangiectasia and Rad3-related inhibitors and cancer therapy: where we stand
por: Mei, Lin, et al.
Publicado: (2019)

Recent Advances in the Use of Metformin: Can Treating Diabetes Prevent Breast Cancer?
por: Hatoum, Diana, et al.
Publicado: (2015)

Metformin: The Answer to Cancer in a Flower? Current Knowledge and Future Prospects of Metformin as an Anti-Cancer Agent in Breast Cancer
por: Samuel, Samson Mathews, et al.
Publicado: (2019)

Cancer Drug Approvals That Displaced Existing Standard-of-Care Therapies, 2016-2021
por: Benjamin, David J., et al.
Publicado: (2022)

Lithium in Cancer Therapy: Friend or Foe?
por: Yang, Chunhao, et al.
Publicado: (2023)

Metformin suppresses proliferation and invasion of drug‐resistant breast cancer cells by activation of the Hippo pathway
por: Liu, Jie, et al.
Publicado: (2020)

A pan-cancer analysis of the role of hexokinase II (HK2) in human tumors
por: Li, Ruiqi, et al.
Publicado: (2022)

Metformin Synergistically Enhanced the Antitumor Activity of Celecoxib in Human Non-Small Cell Lung Cancer Cells
por: Cao, Nini, et al.
Publicado: (2020)

The influence of metformin in the etiology of selected cancers
por: Pawałowska, Monika, et al.
Publicado: (2012)

Repurposing metformin for the treatment of gastrointestinal cancer
por: Cunha Júnior, Ademar Dantas, et al.
Publicado: (2021)

RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential
por: Qu, Jianwei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v3kqck2bpvqabeff397unbejl8